Atrial Tachycardia is a cardiac arrhythmia characterized by a rapid heartbeat originating in the atria, the upper chambers of the heart. Unlike normal heartbeats that are regulated by the sinoatrial (SA) node, individuals with atrial tachycardia experience an abnormal firing of electrical signals from within the atria, leading to a faster heart rate than the typical range of 60 to 100 beats per minute. This condition can be episodic or sustained, causing symptoms such as palpitations, shortness of breath, and dizziness. Diagnosis often involves the use of electrocardiograms (ECGs) to detect the rapid heart rhythm. Management strategies may include medications to control the heart rate, radiofrequency ablation to eliminate the abnormal electrical pathways, or, in severe cases, implantation of a pacemaker. A comprehensive understanding of the underlying causes, risk factors, and available treatment options is crucial for healthcare professionals to effectively manage and improve the quality of life for individuals with atrial tachycardia.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation